Global private equity firm General Atlantic is investing $55 million in the first round to acquire a minority stake in Indonesia-based Kalbe Genexine Biologics (KGBio), according to a press statement.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
